At Artemis Hospitals, Gurugram, our multidisciplinary team takes care of kidney transplants. We have successfully performed cross-blood-group transplants when the donor and recipient blood types do not match.
Our experts use state-of-the-art keyhole and robotic systems for donor nephrectomy and transplantation. Artemis Hospitals transplant department consists of highly trained nephrologists, transplant surgeons, and urologists collaborating under one roof.
Understanding Kidney Failure and Transplant Need
Kidney Failure, also medically known as End-Stage Renal Disease (ESRD) or Stage 5 Chronic Kidney Disease, occurs when your kidneys lose about 85% to 90% of their functional capacity. They can no longer perform their vital job of filtering waste products, toxins, and excess fluids from your bloodstream.
The two most common underlying causes of kidney failure are long-standing, uncontrolled diabetes and high blood pressure (hypertension).
When a patient reaches complete kidney failure, they cannot survive without artificial medical intervention. There are only two life-saving treatments available: Dialysis or a Kidney Transplant.
While dialysis keeps a patient alive, medical professionals universally consider a kidney transplant the gold standard treatment.
Conditions Managed at the Kidney Transplant & Nephrology Department
The Kidney Transplant & Nephrology Department at Artemis Hospitals manages a wide range of kidney-related conditions, from chronic kidney disease and kidney failure to hypertension, kidney infections, and complex electrolyte disorders. The department also provides specialized care for patients requiring dialysis, kidney transplantation, and long-term renal health management.
Chronic Kidney Disease (CKD)
A gradual, long-term loss of kidney function lasting for more than 3 months. The kidneys slowly lose their ability to filter waste. It is a progressive disease divided into 5 stages based on the Estimated Glomerular Filtration Rate (eGFR). Stages 1 to 3 are often asymptomatic.
End-Stage Renal Disease (ESRD)
The final, most advanced stage (Stage 5) of Chronic Kidney Disease. At this point, kidney function drops below 15%. The kidneys can no longer sustain life on their own, making artificial filtration or replacement mandatory.
Diabetic Kidney Disease (Nephropathy)
Kidney damage directly caused by long-standing Diabetes Mellitus. High blood sugar levels over several years damage the microscopic filtering units (nephrons) and blood vessels inside the kidneys. This is the leading cause of Chronic Kidney Disease globally.
Polycystic Kidney Disease (PKD)
A genetic (inherited) disorder that causes numerous fluid-filled cysts to grow in the kidneys. As these cysts multiply and enlarge, they compress and destroy the surrounding healthy kidney tissue. This progressive damage frequently alters the kidney structure and leads to ESRD later in life.
Acute Kidney Injury (AKI)
A sudden, rapid decline in kidney function that happens within a few hours or days. Unlike CKD, AKI is often reversible. It is typically triggered by sudden events like severe dehydration, major infections (sepsis), heavy blood loss, or toxic reactions to certain medications. If left untreated or severe, it can cause permanent damage.
Kidney Failure Requiring Dialysis or Transplant
The state where a patient with ESRD (or severe, unresolving AKI) requires Immediate Renal Replacement Therapy (RRT).Because the biological kidneys can no longer clear toxins or balance fluids, the patient must either start dialysis (hemodialysis/peritoneal) to mechanically clean the blood or undergo a kidney transplant surgery to replace the failed organ.
Specialized Kidney Transplant Programs Available at Artemis Hospitals
At Artemis Hospitals, specialized kidney transplant programs are designed to provide comprehensive care for patients with advanced kidney disease. From detailed pre-transplant evaluations to expert surgical procedures and long-term post-transplant support, the programs focus on improving outcomes and helping patients regain a healthier quality of life.
Living Donor Kidney Transplant
A surgery where a kidney is donated by a healthy, living person, typically a close family member (parents, siblings, spouse). It offers the highest success rates and longest organ lifespan (often lasting 15–20+ years). Because humans can live a perfectly normal life with just one healthy kidney, the donor undergoes a safe laparoscopic or robotic removal, and the organ is transplanted into the recipient immediately.
Deceased Donor Kidney Transplant (Cadaveric)
A transplant where the organ comes from a person who has recently died (usually brain dead in an ICU) and whose family has consented to organ donation.
Patients must register on an official state/national waiting list (managed by NOTTO in India). The wait time can range from months to several years. Once a matching organ becomes available, the hospital must perform the transplant urgently, as the kidney must be transplanted within 24–36 hours of removal from the deceased donor.
ABO-Incompatible Kidney Transplant
An advanced transplant is performed when the living donor and the recipient have mismatched blood groups (e.g., Donor is Type A, Recipient is Type O).
Normally, the recipient’s immune system would instantly reject the mismatched kidney. To prevent this, doctors perform Plasmapheresis (a process that filters out the anti-blood group antibodies from the recipient’s blood) and administer specialized immunosuppressant drugs before the surgery.
This technology allows patients to receive a kidney from a willing family member even if their blood types do not match, eliminating the wait for a deceased donor.
Pediatric Kidney Transplant
Kidney transplantation performed specifically on children and adolescents (under the age of 18). Children have smaller blood vessels and unique psychological, growth, and developmental needs.
The surgery requires specialized pediatric nephrologists, urologists, and downsized surgical equipment. A successful transplant is critical for children with kidney failure because long-term dialysis severely stunts physical growth and brain development.
High-Risk and Complex Kidney Transplant Cases
Transplants involving recipients who have severe medical complications that significantly increase the risk of surgery or organ rejection.
- Highly Sensitized Patients: Patients who have high antibody levels from a previous failed transplant, multiple blood transfusions, or pregnancies (requiring desensitization therapy).
- Dual Transplants: Patients who need a kidney along with another organ simultaneously (e.g., Kidney-Liver or Kidney-Heart transplant).
- Severe Vascular Disease: Patients with heavily calcified or damaged major blood vessels, making it difficult to surgically attach the new kidney.
These cases can be handled by Artemis Hospitals as we have dedicated multi-organ intensive care units and advanced immunological profiling labs.
Advanced Diagnostics and Pre-Transplant Evaluation Facilities
Before a kidney transplant can proceed, a thorough and systematic evaluation of both recipient and donor is non-negotiable. The goal is not simply to confirm surgical eligibility, it is to identify every risk factor, optimize the patient's condition, and lay the groundwork for a successful, complication-free outcome.
At Artemis Hospitals, the pre-transplant evaluation process follows international transplant society protocols and is conducted by a multidisciplinary team working in close coordination.
Kidney Function Tests and Imaging
The evaluation begins with a comprehensive assessment of the recipient's residual kidney function and overall renal anatomy. Serum creatinine, blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), serum electrolytes, and a 24-hour urine protein test establish the functional baseline.
Imaging studies including renal ultrasound, CT angiography of the renal vessels, and in selected cases, MRI map the anatomy of the recipient's urinary tract and vascular system, identifying any structural abnormalities that could complicate surgery or affect the transplanted kidney's placement and blood supply.
HLA Typing and Crossmatch Testing
Human Leukocyte Antigen (HLA) compatibility between donor and recipient is one of the most significant determinants of long-term graft survival. HLA typing is performed using high-resolution molecular techniques to characterise the specific antigen profile of both parties.
The crossmatch test which mixes recipient serum with donor lymphocytes determines whether the recipient already carries antibodies that would immediately attack the new kidney (hyperacute rejection). A negative crossmatch is generally required before transplantation proceeds. Panel Reactive Antibody (PRA) testing further quantifies the recipient's degree of sensitisation and guides decisions on desensitisation protocols where needed.
Donor Compatibility Assessment
For living donor transplants, compatibility assessment extends beyond HLA matching. ABO blood group compatibility is confirmed. Renal anatomy of the donor including the number, size, and vascular architecture of both kidneys is evaluated using CT angiography to determine which kidney is safest to donate while preserving the donor's long-term renal health.
The donor's overall health, kidney function, blood pressure, diabetes risk, and lifestyle factors are assessed to determine suitability and to counsel the donor on long-term implications. Psychological readiness and the voluntariness of donation are also evaluated as part of ethical clearance.
Cardiac and Infection Screening Before Transplant
Patients with end-stage renal disease carry a substantially elevated cardiovascular risk. Pre-transplant cardiac evaluation includes electrocardiography (ECG), echocardiography to assess cardiac function and valve integrity, and stress testing or coronary angiography to detect and address significant coronary artery disease before surgery.
Infection screening is equally important: active or latent infections can become life-threatening under the immunosuppression that follows transplantation. Screening covers Hepatitis B and C, HIV, cytomegalovirus (CMV), Epstein-Barr virus (EBV), tuberculosis (Mantoux and IGRA testing), and dental examination to identify occult oral infections.
Renal Biopsy and Advanced Lab Support
In cases where the underlying cause of kidney failure requires histological confirmation or where the recipient's native kidneys show signs of a recurrent disease that could affect the transplanted organ a renal biopsy may be performed before listing for transplant.
Artemis Hospitals operates a fully equipped advanced laboratory with real-time PCR capabilities, flow cytometry for immune profiling, and specialised histopathology services including electron microscopy for complex renal pathology.
This diagnostic depth supports accurate disease characterisation and allows the transplant team to make better-informed decisions about timing, donor selection, and immunosuppression strategy.
Comprehensive Renal Care and Kidney Transplant Services at the Best Kidney Transplant Hospital in India
Kidney transplantation exists within a broader continuum of renal care and the strength of a transplant programme is inseparable from the quality of the nephrology services surrounding it. Artemis Hospitals provides end-to-end kidney care, from early-stage nephrology management through transplant and into long-term post-operative follow-up, under one roof and through one coordinated clinical team.
Preventive Nephrology and Kidney Disease Management
Not every patient referred to a nephrologist requires a transplant. For those in early-to-moderate chronic kidney disease (CKD) stages, Artemis offers structured preventive nephrology care aimed at slowing disease progression and delaying or in some cases avoiding the need for renal replacement therapy.
Management protocols include blood pressure optimisation (with particular focus on RAAS inhibition through ACE inhibitors or ARBs), diabetic nephropathy management, dietary protein and phosphate modification, and anaemia of chronic kidney disease treatment with erythropoiesis-stimulating agents and iron replacement.
Dialysis and Renal Support Services
For patients who have reached end-stage renal disease while awaiting transplant, or for those who are not transplant candidates, dialysis is a vital bridge and long-term support modality.
Artemis operates both haemodialysis and peritoneal dialysis programmes. The haemodialysis unit is equipped with modern machines capable of delivering high-flux dialysis and haemodiafiltration (HDF), which offers superior middle-molecule clearance compared to standard haemodialysis.
Continuous Renal Replacement Therapy (CRRT) is available in the ICU for critically ill patients with acute kidney injury.
Pre-Transplant Counselling and Evaluation
The period before transplant listing is one of significant anxiety for patients and families. Artemis provides structured pre-transplant counselling that covers the surgical process, expected recovery timeline, immunosuppression regimen and its implications, lifestyle modifications required after transplant, and realistic expectations around outcomes.
Patients receive written information materials and have the opportunity for extended one-on-one discussions with their nephrologist and transplant coordinator. Families are actively included in these sessions, recognising that post-transplant recovery is a household effort, not just an individual one.
Living and Deceased Donor Support Programs
Artemis Hospitals supports both living donor and deceased donor (cadaveric) kidney transplant pathways. The living donor programme includes comprehensive medical, psychological, and ethical evaluation of prospective donors, conducted independently from the recipient's care team to avoid any conflict of interest.
Paired kidney exchange and swap programmes are available for cases where a willing but biologically incompatible donor exists. For deceased donor transplants, Artemis is registered with the relevant state transplant authority and follows all legal and ethical protocols governing organ allocation from brain-dead donors under the Transplantation of Human Organs and Tissues Act (THOTA).
Post-Transplant Recovery and Rehabilitation
The immediate post-operative period is managed in a dedicated transplant ICU where the new kidney's function, fluid balance, and immunosuppression levels are monitored with precision. Rejection surveillance begins from day one.
Once stable, patients are stepped down to a monitored transplant ward before discharge. A structured rehabilitation programme including graduated physical activity, dietary guidance, and return-to-activity planning begins during the hospital stay and continues through outpatient follow-up.
Recovery and Long-Term Follow-Up After Kidney Transplant
Discharge from hospital after a kidney transplant is not the end of the process, it is the beginning of a new chapter that requires consistent medical oversight, lifestyle discipline, and emotional resilience.
Long-term outcomes in transplantation are strongly correlated with the quality of follow-up care and the patient's engagement with their own health. The Artemis transplant team accompanies every patient through this journey with structured protocols and genuine accessibility.
Post-Transplant Monitoring and Follow-Up
In the first weeks after transplant, outpatient visits are frequent:
This is to monitor serum creatinine (the primary indicator of graft function), tacrolimus or cyclosporine drug levels, complete blood counts, liver function, and urine output.
Infection Prevention and Medication Adherence
Immunosuppression that prevents rejection simultaneously blunts the body's defences against infection; this is the central paradox of transplant medicine. Opportunistic infections that a healthy immune system would suppress effortlessly:
- CMV
- Pneumocystis jirovecii pneumonia (PJP)
- Fungal infections
- BK virus nephropathy
Artemis transplant patients receive prophylactic antiviral and antifungal medications during the highest-risk period and are counselled on infection-avoidance behaviour:
- Food hygiene
- Crowd avoidance
- Early reporting of fever
- Respiratory symptoms
Medication adherence is not a peripheral concern; it is the single most modifiable predictor of long-term graft survival. Missing or reducing immunosuppressive doses even briefly can trigger rejection episodes with lasting consequences for kidney function. The Artemis team provides pharmacy support, medication reminders, and transplant coordinator access to help patients maintain adherence over years and decades.
Lifestyle and Dietary Guidance After Kidney Transplant
A functioning transplanted kidney dramatically changes what a patient can eat and how they can live but it does not eliminate the need for discipline. Dietary guidance after transplant addresses several dimensions:
- Fluid intake adequate hydration (typically 2–3 litres daily) supports graft perfusion; this is a welcome change from the fluid restrictions of dialysis.
- Sodium and blood pressure calcineurin inhibitors (tacrolimus, cyclosporine) commonly raise blood pressure; a low-sodium diet complements antihypertensive medications.
- Potassium management early post-transplant hyperkalaemia may require temporary dietary potassium restriction; this typically resolves as kidney function stabilises.
- Phosphate and calcium post-transplant bone disease (from pre-existing hyperparathyroidism and steroid use) requires ongoing monitoring and dietary management.
- Safe food handling immunosuppressed patients should avoid raw or undercooked meat, unpasteurised dairy, and raw shellfish to reduce infection risk.
- Weight management steroid-related weight gain is common and requires proactive dietary guidance and physical activity encouragement.
Physical activity guidance is equally important: most patients can return to light activity within six weeks, with progressive return to normal exercise over three to six months. Contact sports and activities risking abdominal trauma are permanently discouraged.
Long-Term Kidney Function Assessment
Beyond routine creatinine monitoring, Artemis provides structured long-term graft surveillance. Annual protocol biopsies where clinically appropriate allow early detection of subclinical rejection or chronic graft changes before they manifest as measurable function decline.
Donor-specific antibody (DSA) monitoring detects the development of new immune sensitisation that may signal early chronic rejection. Regular eGFR trending over years helps identify patients whose grafts may be at risk and who may benefit from immunosuppression adjustment or intensification.
Emotional and Psychological Support for Patients
Living with a transplanted organ is a profoundly different psychological experience from what most patients anticipate. The gratitude for a new organ coexists with anxiety about rejection, concern for donor wellbeing (in living donor cases), fear of infection, and the psychological weight of lifelong medication dependence.
A subset of patients develop significant depression or anxiety in the post-transplant period, a phenomenon underrecognised in transplant medicine.
Artemis Hospitals provides access to clinical psychologists and psychiatric support as part of the transplant follow-up pathway. Peer support connections linking newly transplanted patients with those who are years post-transplant are facilitated where appropriate, offering a dimension of lived experience and reassurance that clinical consultations alone cannot provide.
Our Kidney Transplant Team at Artemis Hospitals
The outcomes of any transplant programme ultimately rest on the people who deliver it. Artemis Hospitals has assembled a team of dedicated specialists across every discipline required for safe, successful kidney transplantation and long-term renal care.
Nephrologists
The nephrologists at Artemis are trained in the full spectrum of kidney disease management from early CKD through dialysis, transplant listing, post-transplant care, and management of complex complications including rejection, BK nephropathy, and calcineurin inhibitor toxicity. Many have trained at national and international centres of excellence and bring subspecialty expertise in areas such as glomerulonephritis, diabetic nephropathy, and transplant immunology.
Urologists
The urological team contributes essential expertise in the surgical reconstruction of the urinary tract, a critical component of the transplant operation. The transplanted kidney's ureter must be connected to the recipient's bladder with precision to prevent urinary leak, obstruction, or reflux. Artemis urologists also manage post-transplant urological complications including ureteric stricture, lymphocoele, and haematuria, and provide ongoing care for the recipient's native urological conditions.
Transplant Surgeons
The transplant surgical team at Artemis brings extensive experience in both living donor and cadaveric kidney transplantation, including complex cases involving highly sensitised recipients, vascular anomalies, and retransplantation. The surgical approach typically a retroperitoneal placement in the iliac fossa is performed with meticulous attention to vascular anastomosis quality, as the integrity of the arterial and venous connections directly determines early graft function.
Critical Care Specialists
The immediate post-operative period is managed in a dedicated transplant ICU staffed by intensivists experienced in the specific demands of transplant critical care: fluid management during the vulnerable early reperfusion period, haemodynamic monitoring, immunosuppression initiation, infection surveillance, and rapid response to early graft dysfunction. The availability of CRRT in the ICU provides a safety net for patients whose grafts take longer to establish function (delayed graft function), allowing adequate time for recovery without harm.
Why Choose Artemis Hospitals as the Best Kidney Transplant Hospital in India?
Choosing where to have a kidney transplant is one of the most consequential healthcare decisions a family will ever make. The factors that determine this decision should go beyond reputation; they should include measurable clinical quality, institutional depth, and the experience of patients who have walked this path before. Here is why Artemis Hospitals stands out as a leading kidney transplant centre in India.
The Artemis transplant team has collectively performed hundreds of kidney transplants, including complex cases that other centres may decline highly sensitised patients requiring desensitisation protocols, paediatric transplants, ABO-incompatible transplants, and retransplantation after prior graft failure. Experience in complex cases is the most reliable indicator of a team's preparedness for the unexpected, which arises in every transplant programme.
Kidney Transplant Support for International Patients in India
India has become an increasingly prominent destination for international patients seeking kidney transplantation particularly for patients from South Asia, the Middle East, Africa, and Southeast Asia, where either transplant infrastructure is limited or waiting times for deceased donor organs are prohibitively long.
Artemis Hospitals offers a dedicated international patient services programme that addresses the practical, logistical, and emotional dimensions of receiving transplant care far from home.
International patients receive a single point of contact through the international patient coordinator, who manages appointment scheduling, medical record translation and review, cost estimation and treatment planning, visa assistance documentation, and accommodation arrangements for the patient and accompanying family members. All clinical consultations can be initiated remotely through teleconsultation, allowing the transplant team to review records, request additional investigations, and provide a preliminary assessment before the patient travels to Gurugram.
Language support is available for major international languages through professional medical interpreters, and the international patient services team is accessible across time zones for queries and concerns throughout the treatment journey.
How to Book an Appointment at a Kidney Transplant Hospital in India?
For patients and families at the point of considering a kidney transplant whether newly diagnosed with end-stage renal disease, currently on dialysis and exploring options, or seeking a second opinion on a previous evaluation, taking the first step toward specialist consultation is straightforward at Artemis Hospitals.
Initial consultations with the nephrology and transplant team at Artemis can be booked for in-person visits or conducted via secure teleconsultation for patients who are geographically distant or prefer a remote first discussion.
Second opinions are actively welcomed. Patients who have received a transplant recommendation from another centre, or who have been told they are not transplant candidates and wish to explore whether that assessment holds at Artemis, can arrange a formal second opinion consultation with the transplant team.
Reviewed by Dr. Varun Mittal
Head - Kidney Transplant
Artemis Hospitals
